2m 2m 2m 2m 2m 2m 2m
Geron (GERN)
NASDAQ
$1.35-$0.005 (-0.37%)
Price as of Jun 23, 2026 7:46 PM EDT- $859.6MMarket Cap
- -5.63%1-Year Change
- BiotechnologyIndustry
Geron (GERN)
$1.35-$0.005 (-0.37%)
GERN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.35 | ||
Change | +$0.08 (+6.35%) | ||
Open | $1.32 | ||
High | $1.36 | ||
Low | $1.29 | ||
Previous Close | $1.34 | ||
Volume | 13,103,262 | ||
30-Day Average Volume | 12,999,413 | ||
1-Week Change | 16.52% | ||
1-Month Change | 4.69% | ||
1-Year Change | -5.63% | ||
3-Year Change | -57.05% | ||
5-Year Change | -14.65% | ||
Fundamentals | |||
Shares Outstanding | 641.5M | ||
Total Assets | $534.1M | ||
Market Cap | $859.6M | ||
Enterprise Value | $910.6M | ||
Period: QTR TTM FY | |||
Revenue | $51.8M | ||
Net Income | -$3.6M | ||
Free Cash Flow | -$62.9M | ||
EBIT | $58,000.00 | ||
EBITDA | $192,000.00 | ||
Net Working Capital | $425.0M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | 4,743 | ||
Enterprise Value/Revenue | 18 | ||
P/B | 4 | ||
P/E | -134 | ||
PEG | -2 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue